RE:RE:sh*ts and giggles ...kentucky77 wrote: Agreed, I sense the time is right for EDNO to conveniantly off-load Palidin to the highest bidder and we both know who has the cash and the burning desire. GLTU
Ya - been wondering about that.
Goodman isn't willing to overpay ... but ...
there's roughly 69 drugs that are bringing in sales of $24M USD/qtr.
The new ENDO CEO knows that he's not going to fetch much on the open market for this portfolio and if sales start to decline, he's really going to have trouble offloading.
This just isn't an area where we wants to focus - the rest of his business in bleeding.
Strategic review should lead to something ... sooner than later ... you'd think.